A Phase III Double-Blind, Placebo Controlled Study Of The Safety And Efficacy Of 10mg Atrasentan in Men with Metastatic, Hormone-Refractory Prostate Cancer

  • James, Nicholas (Principal Investigator)

Project Details

Short titleA Phase III Double-Blind, Placebo Controlled Study Of The Safety And Efficacy Of 10mg Atrasentan in Men with Metastatic, Hormone-Refractory Prostate Cancer
StatusFinished
Effective start/end date1/01/0231/12/05

Funding

  • PPD GLOBAL LTD